AAIC 2026: Where Alzheimer’s Prevention, Treatment, and Diagnosis Stand Now
The Alzheimer’s Association International Conference (AAIC) 2026 offered one of the clearest snapshots yet of a field moving on three fronts at once: preventing decline through lifestyle, altering the disease course with drugs, and diagnosing pathology from a simple blood draw. Read More
What drives consumer choices? Our latest Neuromarketing study reveals.
We are pleased to announce that a new research article from our lab has been published in Corporate Communications: An International Journal. The study investigates how different types of price discounts influence consumers’ purchase intentions using eye tracking (ET) and electroencephalography (EEG) in a realistic supermarket simulation. Read More
Published! Comparative Analysis of Muscle Synergies in Gait of Stroke Patients and Healthy Controls [Frontiers in Human Neuroscience]
Our latest publication in Frontiers in Human Neuroscience, study explores muscle synergies during gait in subacute stroke patients, offering insights into motor control and recovery mechanisms. Key Findings This study analysed muscle synergies in subacute stroke patients’ gait, comparing paretic and non-paretic limbs with healthy individuals, and explored the consistency of synergistic activation across trials. Read More
EEG as a Scalable Tool for Early Detection of Alzheimer’s Disease
We have published a significant study in the Journal of Dementia and Alzheimer’s Disease, demonstrating the potential of electroencephalography (EEG) to reliably track changes across the Alzheimer’s disease (AD) spectrum. Our findings suggest that analyzing brain activity through EEG-based connectivity patterns could provide a cost-effective and noninvasive method for earlier diagnosis and intervention in AD. Read More
